Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Intensive Lipid-Lowering Therapy With a Statin-Ezetimibe Combination (Without Aspirin) vs. Statin Monotherapy (With Aspirin) In Asymptomatic Patient With Coronary Artery Calcification

NCT06722521 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT06722521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06722521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Intensive Lipid-Lowering Therapy With a Statin-Ezetimibe Combination (Without Aspirin) vs. Statin Monotherapy (With Aspirin) In Asymptomatic Patient With Coronary Artery Calcification
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
July 9, 2025
Completion date
October 31, 2032
Enrollment
7,435 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary prevention, vascular calcification